Systemic Lupus Erythematosus Research
Moving in Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Nature Reviews Rheumatology, The Lancet Rheumatology, Kidney International, Journal of Clinical Investigation, Journal of the American Society of Nephrology and European Heart Journal.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 110
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Systemic Lupus Erythematosus Research
Newest first · last 60 days
AI summary · may contain errors
Dual CD21 blockade with a CD21-blocking antibody on both B cells and follicular dendritic cells synergistically suppresses germinal center activity and autoimmunity in lupus-prone mice.
- Open access
AI summary · may contain errors
A 68Ga-NOTA-ssDNA PET/CT probe enables early detection of renal immune complex deposition in 10-week-old MRL/lpr lupus mice, preceding conventional renal marker changes by ~2 weeks.
- Open access
AI summary · may contain errors
Sjögren disease shows systemic extra-glandular involvement at diagnosis in most patients, with interstitial lung disease, arthritis, and renal disease linked to T cell–predominant inflammation.
AI summary · may contain errors
Rheumatoid arthritis low inflammatory activity (RALI) thresholds—M-DAS28 <1.4, Modified SDAI ≤3, and Modified CDAI ≤2—identify a state linked to similar radiographic progression.
- Open access
AI summary · may contain errors
The 2025 GLADEL-PANLAR guidelines update organ-based systemic lupus erythematosus treatment algorithms, integrating newly approved therapies and randomized trial evidence to support earlier biologic use.
- Open access
AI summary · may contain errors
In TopoI-induced systemic sclerosis mice, murinised efgartigimod FcRn blockade ameliorates dermal and pulmonary fibrosis comparably to nintedanib.
- Open access
AI summary · may contain errors
Obinutuzumab β plus standard therapy increased SRI-4 responses at week 12 in Chinese adults with active systemic lupus erythematosus, from 34% to 52%.
AI summary · may contain errors
Weekly 1 mg/kg subcutaneous 1687 treatment in severe Trex1−/− AGS1 mice significantly improves survival over 250 days and partially normalizes growth and disease signs.
- Open access
AI summary · may contain errors
In nephrotoxic serum nephritis, embryonically derived kidney-resident macrophages enriched in the outer medulla and corticomedullary region support cortical monocyte recruitment, linked to CCL12/CCR2 signaling.
AI summary · may contain errors
Modified immune cell therapy using mitomycin C in NZB/W F1 mice reduces lupus nephritis progression, lowering protein excretion and serum creatinine versus controls at standard dose.
- Open access
AI summary · may contain errors
In treatment-naive systemic lupus erythematosus patients, circulating CD8+ CD69+ CD103+ tissue-resident memory-like cells are more frequent than in rheumatoid arthritis and healthy donors, and link to anti-double-stranded DNA and complement activity.
- Open access
AI summary · may contain errors
Black patients with active moderate-to-severe systemic lupus erythematosus in the BILAG-BR had lower odds of major clinical response after treatment escalation than White patients (OR 0·13, 95% CI 0·02–0·88).
- Open access
AI summary · may contain errors
B-cell–specific deletion of Rabggta, encoding GGTase II, impairs antibody responses and germinal center formation, and reduces bone marrow plasma cells in mice.
AI summary · may contain errors
APS remains rare in population-based studies, and catastrophic APS is even rarer, with best characterization coming from registry data rather than broad epidemiologic estimates.
AI summary · may contain errors
Canagliflozin ameliorated experimental ANCA-associated vasculitis in rats, reducing kidney injury, pulmonary hemorrhage, and T-lymphocyte infiltration with broad suppression of pathogenic T-cell subsets.
- Open access
- 1 cites
AI summary · may contain errors
Patients with autoimmune rheumatic diseases face increased infection risk, and suboptimal uptake of routine vaccines like influenza and pneumococcal remains a key gap despite heightened concerns during outbreaks.
- 2 cites
AI summary · may contain errors
Increasing purine biosynthesis with 5-aminoimidazole-4-carboxamide riboside (AICAr) mitigated APOL1 G2/G2 risk variant–linked kidney injury, reducing albuminuria in IFN-γ treated transgenic mice.
- Open access
- 2 cites
Browse JClub
Journals this month
- bioRxiv6357
- medRxiv1736
- PNAS556
- JAMA352
- Sci Adv330
- Cell Rep314
- Environ Res213
- BMJ209
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- NEJM148
- New Phytol145
- Curr Biol130
- Nature127
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
